Pharmaceutical

CORRECTION BY SOURCE: Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA

The following CORRECTS and REPLACES the release that was issued earlier today: Updated partner for VOC detection platform developmentFrom giving…

3 days ago

Lab Automation Market to Hit USD 7.71 Billion by 2029 with 6.9% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ -- The global lab automation market is expected to reach USD 7.71 Billion by…

3 days ago

MOBILion Systems Partners with Leading Researcher at University of Duisburg-Essen to Advance Metabolomics Research and Discovery

CHADDS FORD, Pa., Dec. 18, 2024 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, today announced a new…

3 days ago

DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data

Leading cloud-based enterprise platform for precision health data empowers biopharma companies with actionable insights to accelerate drug discovery and development     SAN ANTONIO,…

3 days ago

Analyst Report Ranks Northern Light a “Leader” and a “Customer Favorite” Among Market and Competitive Intelligence Platform Providers

BOSTON, Dec. 18, 2024 /PRNewswire/ -- Northern Light (www.northernlight.com) announced today that Forrester, one of the world's foremost research and…

3 days ago

3Gen Consulting Secures USD 22 Million Investment from Piramal Alternatives to Revolutionize Healthcare Revenue Cycle Management

MUMBAI, India, Dec. 18, 2024 /PRNewswire/ -- 3Gen Consulting, a leading provider of healthcare consulting and revenue cycle management (RCM)…

4 days ago

PharmPix Corp. Joins Forces With Mark Cuban Cost Plus Drug Company to Revolutionize Pharmacy Benefits

Revolutionizing Pharmacy Benefits: PharmPix and Cost Plus Drugs Partner to Deliver Unprecedented Medication Cost Transparency and Affordability DALLAS, TEXAS /…

4 days ago

Phase 2 Study Initiated to Evaluate Jaguar Health’s Crofelemer for Microvillus Inclusion Disease (MVID), an Ultrarare Congenital Diarrheal Disorder

The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies -…

4 days ago

Verisante Technology, Inc. Announces RTO Update:

RTO Partner SunRegen Healthcare AG Closes Private Placement for $2.1 Million VANCOUVER, BC / ACCESSWIRE / December 18, 2024 /…

4 days ago

Lexaria Forms New Scientific Advisory Board

North American drug delivery development experts added to help guide Lexaria's strategic plans KELOWNA, BC / ACCESSWIRE / December 18,…

4 days ago